Announcement on the completion of cancellation of some special accounts for raised funds of Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group
Stock Code: 600380 Stock Name: Joincare Pharmaceutical Group Industry Co.Ltd(600380) Announcement No.: pro 2022-016
Joincare Pharmaceutical Group Industry Co.Ltd(600380)
Announcement on the completion of cancellation of some special accounts for raised funds
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Basic information of raised funds
With the approval of the reply on approving Joincare Pharmaceutical Group Industry Co.Ltd(600380) share allotment (zjxk [2018] No. 1284) issued by the China Securities Regulatory Commission, the company allotted 365105066 new shares to the original shareholders. The total amount of funds actually raised in this allotment is 1715993810.20 yuan, after deducting the issuance expenses of 46253565.29 yuan, the net amount of funds raised is 1669740244.91 yuan. As of October 16, 2018, the above raised funds had been in place, which was verified by Ruihua Certified Public Accountants (special general partnership) and issued the Joincare Pharmaceutical Group Industry Co.Ltd(600380) capital verification report (Ruihua Yan Zi [2018] No. 40060006).
2、 Deposit and management of raised funds
In order to standardize the management of the raised funds of the company and protect the rights and interests of investors, in accordance with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the raised funds of listed companies, the guidelines for the self discipline supervision of listed companies of Shanghai Stock Exchange No. 1 – standardized operation, and the provisions of laws, regulations and normative documents, In combination with the actual situation of the company, the measures for the management of Joincare Pharmaceutical Group Industry Co.Ltd(600380) raised funds are formulated to store the raised funds in a special account, Joincare Pharmaceutical Group Industry Co.Ltd(600380) (hereinafter referred to as the company or Joincare Pharmaceutical Group Industry Co.Ltd(600380) ) and the wholly-owned subsidiaries of the company, Shenzhen Haibin Pharmaceutical Co., Ltd. (hereinafter referred to as Shenzhen Haibin), health pharmaceutical (China) Co., Ltd. (hereinafter referred to as health China) Joincare Pharmaceutical Group Industry Co.Ltd(600380) Haibin Pharmaceutical Co., Ltd. (hereinafter referred to as: Joincare Pharmaceutical Group Industry Co.Ltd(600380) Haibin), Shenzhen Madame Pharmaceutical Co., Ltd. (hereinafter referred to as Madame pharmaceutical), the sponsor Minsheng Securities Co., Ltd. (hereinafter referred to as Minsheng securities) and the commercial bank storing the raised funds signed the tripartite supervision agreement on the storage of the special account for raised funds.
As of the date of this announcement, the details of the special account for raised funds opened by the company are as follows:
No. item name account opening entity bank name account No. remarks
1 Joincare Pharmaceutical Group Industry Co.Ltd(600380) China Industrial And Commercial Bank Of China Limited(601398) Co., Ltd. 4000029129200529474
Raised funds general account company Shenzhen Hongwei sub branch
2 Joincare Pharmaceutical Group Industry Co.Ltd(600380) China Merchants Bank Co.Ltd(600036) 755901281810702
Shenzhen Yuncheng sub branch (note)
Announcement on the completion of cancellation of some special accounts for raised funds of Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group
3 Zhuhai great health industry base health China Industrial And Commercial Bank Of China Limited(601398) Co., Ltd. 4000029129200529625 Shenzhen Hongwei sub branch of the construction company is cancelled this time
4 Haibin pharmaceutical Pingshan pharmaceutical products Shenzhen Haibin China Merchants Bank Co.Ltd(600036) 755901221810903
Industrialization base construction Shenzhen Yuncheng sub branch (note)
Haibin pharmaceutical Pingshan Pharmaceutical Co., Ltd
5 industrialization base construction, Haibin Joincare Pharmaceutical Group Industry Co.Ltd(600380) China China Everbright Bank Company Limited Co.Ltd(601818) Co., Ltd. 56510188000017136
Pharmaceutical Pingshan pharmaceutical industrialization Haibin Company Shenzhen University City sub branch
Base expansion project
6 information platform construction project Joincare Pharmaceutical Group Industry Co.Ltd(600380) China Merchants Bank Co.Ltd(600036) 7559012810810
shenzhen branch
7 Joincare Pharmaceutical Group Industry Co.Ltd(600380) Industrial Bank Co.Ltd(601166) 337110100100319937
Shenzhen Bagualing sub branch
8 wife pharmaceutical China Industrial And Commercial Bank Of China Limited(601398) Co., Ltd. 40000219200079006
New product R & D project company Shenzhen Hongwei sub branch
9 Shenzhen Haibin Industrial Bank Co.Ltd(601166) 337050100100722059
Shenzhen Bagualing sub branch
10 Joincare Pharmaceutical Group Industry Co.Ltd(600380) China China Everbright Bank Company Limited Co.Ltd(601818) Co., Ltd. 56510188000041754
Haibin Company Shenzhen University City sub branch
Note: the name of the above deposit bank is changed from China Merchants Bank Co.Ltd(600036) Shenzhen Yuanxing sub branch to China Merchants Bank Co.Ltd(600036)
Shenzhen Yuncheng sub branch
3、 Cancellation of some special accounts for raised funds this time
On January 24, 2022, the company held the 8th meeting of the 8th board of directors, deliberated and adopted the
The proposal on some projects invested with raised funds agrees that the company will change the construction project of Zhuhai great health industry base into
New product R & D project, Haibin pharmaceutical Pingshan pharmaceutical industrialization base expansion project, information platform construction project.
The proposal was deliberated and approved by the company’s first extraordinary general meeting in 2022 on February 11, 2022. specific
See the relevant announcements disclosed by the company on January 25, 2021 and February 12, 2022 (p.2022) for details-
007, p.2022-014).
In order to standardize the management of fund-raising account, the special fund-raising account of the former Zhuhai great health industry base construction project
(Account No.: 4000029129200529625) no longer used. As of the date of this announcement, the company has raised the funds
The balance of the special fund account (including interest income) has been transferred to the special fund raising account of Joincare Pharmaceutical Group Industry Co.Ltd(600380) (Account No.: 400002919200529474), and the cancellation procedures of the special fund raising account have been completed. The company, its wholly-owned subsidiary health China and Minsheng securities, and
Industrial And Commercial Bank Of China Limited(601398) Shenzhen Hongwei sub branch signed the special account for raised funds
The three party supervision agreement on household storage shall be terminated accordingly.
It is hereby announced.
Joincare Pharmaceutical Group Industry Co.Ltd(600380)
February 17, 2002
